CD4+CD25highCD226low/- Cells: an Innovative Approach to Identify Human Regulatory T Cells
Yu Liu,Guangying Qi,Julie Wang,Feng Huang,Joseph A. Bellanti,Song Guo Zheng
DOI: https://doi.org/10.1016/j.jaci.2020.06.029
IF: 14.29
2021-01-01
Journal of Allergy and Clinical Immunology
Abstract:Accumulating evidence indicates that CD25+CD4+ regulatory T (Treg) cells contribute to the maintenance of immunologic self-tolerance and negative control of various immune responses1Horwitz D.A. Zheng S.G. Gray J.D. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other.Trends Immunol. 2008; 29: 429-435Abstract Full Text Full Text PDF PubMed Scopus (277) Google Scholar and it can be exploited to prevent and treat autoimmune diseases and allergy.2Wing J.B. Tanaka A. Sakaguchi S. Human FOXP3(+) Regulatory T cell heterogeneity and function in autoimmunity and cancer.Immunity. 2019; 50: 302-316Abstract Full Text Full Text PDF PubMed Scopus (189) Google Scholar Recently, CD25+CD4+ Treg cells have been applied in the field of transplantation to establish the donor-specific tolerance.2Wing J.B. Tanaka A. Sakaguchi S. Human FOXP3(+) Regulatory T cell heterogeneity and function in autoimmunity and cancer.Immunity. 2019; 50: 302-316Abstract Full Text Full Text PDF PubMed Scopus (189) Google Scholar Although CD25+CD4+ Treg cells have broad potential for treating autoimmune diseases, it is still difficult to accurately distinguish inhibitory Treg cells from activated CD25+ conventional T cells.3Baecher-Allan C. Brown J.A. Freeman G.J. Hafler D.A. CD4+CD25high regulatory cells in human peripheral blood.J Immunol. 2001; 167: 1245-1253Crossref PubMed Scopus (1532) Google Scholar CD25+CD4+ T cells could contain up to 30% CD4+ non-Treg cells, leading to contamination of the Treg cells isolated for therapeutic purposes and the failure of clinic application.3Baecher-Allan C. Brown J.A. Freeman G.J. Hafler D.A. CD4+CD25high regulatory cells in human peripheral blood.J Immunol. 2001; 167: 1245-1253Crossref PubMed Scopus (1532) Google Scholar The FoxP3 gene encodes a forkhead box P3 transcription factor that is specifically expressed in naturally arising CD25+CD4+ regulatory T cells and has has proved to be a major transcriptional factor that modulates CD25+CD4+ Treg cell development and function. Although it is unclear whether all Treg cells are FoxP3+ or all FoxP3+ T cells are regulatory cells and FoxP3 is also inducibly expressed on activated human CD4+ non-Treg cells, the FoxP3 protein remains the best and most specific marker of Treg cells to date. Given that FoxP3 is an intracellular molecule, detection of FoxP3 requires fixation and permeabilization of cells; thus, it cannot be applied in viable Treg cell isolation for functional studies or ex vivo expansion as a prelude to therapeutic administration. Therefore, it would be of interest to identify the cell surface marker(s) that correlate with FoxP3 to determine actual Treg cell populations. Traditionally, measurement of the low-expression CD127, the α-chain of the IL-7 receptor, as a surface marker has been widely used to identify human CD4+ Treg cells, especially when combined with CD25 expression. However, some studies have suggested that these surface markers do not represent equivalent FoxP3 populations of Treg cells.4Klein S. Kretz C.C. Krammer P.H. Kuhn A. CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood.J Invest Dermatol. 2010; 130: 492-499Abstract Full Text Full Text PDF PubMed Scopus (65) Google Scholar For example, there was a high percentage (34.0% ± 15.1%) of CD4+ CD25highCD127low/– cells that did not express FoxP3,4Klein S. Kretz C.C. Krammer P.H. Kuhn A. CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood.J Invest Dermatol. 2010; 130: 492-499Abstract Full Text Full Text PDF PubMed Scopus (65) Google Scholar which is consistent with our findings (see Fig E1, A in this article’s Online Repository at www.jacionline.org). We therefore question whether there is a better surface marker or combination of markers that could be better correlated with FoxP3 or its functional properties. Miyara et al have established that the combination of CD45RA and CD25 is able to better identify the Treg cell population.5Miyara M. Yoshioka Y. Kitoh A. Shima T. Wing K. Niwa A. et al.Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.Immunity. 2009; 30: 899-911Abstract Full Text Full Text PDF PubMed Scopus (1488) Google Scholar They divided CD4+ cells into 3 phenotypically and functionally distinct subpopulations: type 1 Treg cells (CD4+CD45RA+CD25++ resting Treg cells), type 2 Treg cells (CD4+CD45RA–CD25+++ activated Treg cells), and type 3 Treg cells (CD4+CD45RA–CD25++ nonsuppressive T cells).5Miyara M. Yoshioka Y. Kitoh A. Shima T. Wing K. Niwa A. et al.Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.Immunity. 2009; 30: 899-911Abstract Full Text Full Text PDF PubMed Scopus (1488) Google Scholar The type 2 Treg cell population, with a higher suppressive function than that of CD4+CD25highCD127low/– T cells, presumably best represents the favorable Treg cells. Nonetheless, because the number of cells in that population is extremely low, this method may miss some real Treg cells, thus limiting the isolation efficiency. CD226, also known as DNAX accessory molecule 1 (DNAM-1), is a costimulatory receptor that is mainly expressed on activated T cells and natural killer (NK) cells. CD226 is involved in NK cell– and T-cell–mediated cytotoxicity and proliferation, and it is regarded as a proinflammatory mediatror.6Yang M. Liu Y. Mo B. Xue Y. Ye C. Jiang Y. et al.Helios but not CD226, TIGIT and Foxp3 is a potential marker for CD4(+) Treg cells in patients with rheumatoid arthritis.Cell Physiol Biochem. 2019; 52: 1178-1192Crossref PubMed Scopus (18) Google Scholar The detailed functions of CD226 in Treg cells is still elusive. It has been reported that CD226 was rarely expressed in Treg cells6Yang M. Liu Y. Mo B. Xue Y. Ye C. Jiang Y. et al.Helios but not CD226, TIGIT and Foxp3 is a potential marker for CD4(+) Treg cells in patients with rheumatoid arthritis.Cell Physiol Biochem. 2019; 52: 1178-1192Crossref PubMed Scopus (18) Google Scholar and CD226+ NK cells downregulated FoxP3 expression in Treg cells.7Parmiani G. Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cells.Immunol Today. 1993; 14: 536-538Abstract Full Text PDF PubMed Scopus (75) Google Scholar Therefore, we inferred that CD226 signaling might have an effect opposite that of FoxP3 signaling and the activation of FoxP3 in Treg cells could restrict CD226 expression in Treg cells. Therefore, CD226low/– in cytometric analysis of cells is probably a previously neglected characteristic of Treg cells. In the current study, we analyzed circulating Treg cells in blood from 10 healthy adult donors by using flow cytometry. We identified an obvious group of CD4+CD25highCD226low/– cells in human peripheral blood (Fig 1, A), accounting for 6.30% ± 0.63% of CD4+ T cells, which is somewhat lower than the percentage of CD4+CD25highCD127low/– cells (7.93% ± 0.32%) and significantly higher than the percentage of type 2 Treg cells (1.14% ± 0.19%) (Fig 1, B). An in vitro functional test based on a terminal carboxyfluorescein succinimidyl ester dilution assay of labeled CD8+ T cells showed that the CD4+CD25highCD226low/– T-cell subset had a stronger suppressive function than the CD4+CD25highCD127low/– Treg cell, type 1 Treg cell, and type 3 Treg cell subpopulations, with suppressive efficiency equivalent to that of type 2 Treg cells (Fig 1, C). When PBMCs were cocultured with Treg cells, the production of IFN-γ in CD4 responder T cells decreased at 72 hours after stimulation, which is consistent with previous results.8Sojka D.K. Fowell D.J. Regulatory T cells inhibit acute IFN-γ synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10.Proc Natl Acad Sci U S A. 2011; 108: 18336-18341Crossref PubMed Scopus (61) Google Scholar Strikingly, among all the Treg cell subsets, CD4+CD25highCD226low/– T cells displayed stronger suppressive efficiency for inhibition of IFN-γ production than other the Treg cell subpopulations did (Fig 1, D). In addition, the expression of FoxP3, in CD4+CD25highCD226low/– T cells was significantly higher than in CD4+CD25highCD127low/– T cells, type 1 Treg cells, and type 3 Treg cells (see Fig E1, A). Helios is expressed in the majority of Treg cells and is required for maintenance of their suppressive phenotype.6Yang M. Liu Y. Mo B. Xue Y. Ye C. Jiang Y. et al.Helios but not CD226, TIGIT and Foxp3 is a potential marker for CD4(+) Treg cells in patients with rheumatoid arthritis.Cell Physiol Biochem. 2019; 52: 1178-1192Crossref PubMed Scopus (18) Google Scholar We found that the expression of Helios in CD4+CD25highCD226low/– T cells was significantly higher than in CD4+CD25highCD127low/– T cells (see Fig E1, B). Moreover, this population expressed higher levels of IL-10, CTLA-4, TIGIT, and ICOS (all of which are important Treg cell signatures) than most other Treg cell populations did (see Fig E2 in this article’s Online Repository at www.jacionline.org). Although TGF-β is considered to be related to the inhibitory function of Treg cells, our results have shown that the expression of latency-associated peptide (LAP [a TGF-β precursor]) on the surface of Treg cells has no correlation with their inhibitory function (see Fig E3 in this article’s Online Repository at www.jacionline.org). These results suggest that an assay targeting CD4+CD25highCD226low/– T cells may be better than other Treg cell identification methods. To determine whether CD4+CD25highCD226low/– T cells were a subset of CD4+CD25highCD127low/– Treg cells, we examined the expression of CD127 on CD4+CD25highCD226low/– T cells. The examination showed that there is a percentage (ie, 6.74% ± 1.83%) of CD4+CD25highCD226low/– T cells that highly expressed CD127 (see Fig E4 in this article’s Online Repository at www.jacionline.org). Meanwhile, we detected the expression of CD226 on the CD4+CD25highCD127low/– Treg cells (24.87%), whereas 75.13% ± 6.68% of CD4+CD25highCD127low/– T cells showed low expression of CD226 (see Fig E4). These results indicated that the group of CD4+CD25highCD226low/– Treg cells did not completely overlap with the group of CD4+CD25highCD127low/– Treg cells. To verify whether both CD226 and CD127 could be used simultaneously to improve the identification of Treg cells, we compared the suppressive function of CD4+CD25highCD127low/CD226low/– T cells with that of CD4+CD25highCD226low/– T cells. The comparison showed that there is no significant difference in suppressive efficiency between the 2 T-cell subsets (see Fig E5 in this article’s Online Repository at www.jacionline.org). According to the statistics, the percentage of CD4+CD25highCD127low/–CD226low/– T cells among CD4 T cells is 5.88% ± 0.23% in human peripheral blood, which is lower than the percentage of CD4+CD25highCD226low/– cells (6.30% ± 0.63%). These results suggest that integrating CD25high and CD226low/– as Treg cell markers can improve the identification efficacy of Treg cells. Overall, our study demonstrated that CD226 combined with CD25 could identify a group of T cells with efficient immunosuppressive function. CD4+CD25highCD226low/– T cells displayed higher suppressive capacity than did the classic CD4+CD25highCD127low/– T cells, type 1 Treg cells (CD4+CD45RA–CD25++) and type 3 Treg cells (CD4+CD45RA+CD25++), with the suppressive capacity of CD4+CD25highCD226low/– T cells being equivalent to that of type 2 Treg cells (CD4+CD45RA–CD25+++). Compared with CD4+CD25+CD127low/– T cells, the CD4+CD25highCD226low/– subset showed higher expression of FoxP3, Helios, IL-10, CTLA-4, ICOS and TIGIT. In addition, the CD4+CD25highCD226low/– cell subset of leukocytes was far more abundant than the subset of type 2 Treg cells, suggesting that the latter method of assay misses some real Treg cells. Recently, investigators have reported that CD226 attenuates classic Treg cells' suppressive capacity via CTLA-4 and TIGIT during experimental autoimmune encephalomyelitis.9Wang N. Liang S. Jin J. Fang L. Ma Q. Wang X. et al.CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE.Immunol Res. 2019; 67: 486-496Crossref PubMed Scopus (6) Google Scholar These findings also support the contention that CD4+CD25highCD226low/– T cells are a promising group of Treg cells that may potentially contribute to study of human Treg cells and their application to disease therapy. The following fluorescence-conjugated human antibodies from Biolegend (San Diego, Calif) were used for flow cytometric analysis. Cells were stained with 7-AAD viability dye, anti–CD4 PerCP-Cy5.5 or allophycocyanin (APC), anti-CD45RA fluorescein isothiocyanate, anti-CD25 phycoerythrin (PE), anti-CD127 PE-Cy7, anti–IL-10 PE, anti–IFN-γ PerCP-Cy5.5, anti-LAP PE, anti-CD226 APC, anti–CTLA-4 APC, anti-ICOS APC, anti-TIGIT APC, anti-Helios Alexa Fluor 488, and anti-FoxP3 Alexa Fluor 647 specific antibodies. FoxP3 and Helios intracellular staining was performed on fixed and permeabilized cells via Cytofix/Cytoperm (e-Bioscience). For detection of intracellular cytokine production, CD4+ T cells were stimulated with 20 ng/mL of phorbol myristate acetate, 200 ng/mL of ionomycin for 5 hours, and 5 mg/mL of brefeldin A for 4 hours at 37 °C, and were then stained with anti–IL-10 PE or anti–IFN-γ PerCP-Cy5.5 after fixation and permeabilization. Data were acquired by using a FACSCanto II flow cytometry system and analyzed by using FACSDiva software (BD) and FlowJo software (Treestar). Statistical comparisons were performed with the nonparametric Mann-Whitney U test. PBMCs were isolated from blood cones obtained from healthy donors (Guangzhou Blood Center, Guangzhou, China) by Ficoll-Hypaque density gradient centrifugation (using Lymphocyte Separation Medium Lymphoprep [PAA Laboratories]). The PBMCs were stained with mAbs and Treg cell subsets were isolated by fluorescence-activated cell sorting (FACS) using a BD FACSAria I cell sorter. The total CD4+CD25+ Treg cell population (mean purity of the total sorted live CD4+ cells, 30.5% [range, 23.3%-35.6%]) was sorted into 5 phenotypically distinct subpopulations based on expression of CD127, CD45RA, and CD226: CD4+CD25highCD226low/–, CD4+CD25highCD127low/–, CD4+CD45RA+CD25++, CD4+CD45RA–CD25+++, and CD4+CD45RA–CD25++. The mean purity of the sorted populations was 89.4% (range, 81.0%-95.3%) of the total live CD4+ T cells. To examine the suppressive activity of Treg cells as described in Zheng et al,E1Zheng S.G. Wang J.H. Gray J.D. Soucier H. Horwitz D.A. Horwitz, Natural and induced CD4+CD25+ cells educate CD4+CD25− cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10.J Immunol. 2004; 172: 5213-5221Crossref PubMed Scopus (541) Google Scholar PBMCs (4 × 105) were stained with carboxyfluorescein succinimidyl ester (CFSE) at 2 mM and cultured with Treg cell subsets (2 × 105) in a 2:1 ratio. The cell mixtures were stimulated with soluble anti-CD3 (0.025 mg/mL) in a 96-well flat bottom plate at 37°C in 5% CO2 for 3 days and analyzed by FACS. The proliferative levels of CFSE-CD8+ cells were judged by the rates and intensity of CFSE dilution measured with flow cytometry. For IFN-γ analysis, 3 × 105 PBMCs and 1.5 × 105 cells of the different Treg cell subsets (at a 1.5:1 ratio) were cocultured with LPS (100 ng/mL) in a 96-well flat bottom plate at 37°C in 5% CO2 for 3 days and then stained and analyzed by FACS. RPMI 1640 medium supplemented with 10%1x FBS, 10 mM HEPES, 1×Non-Essential Amino Acids, 1 mM sodium pyruvate, and 100 U/mL of penicillin or streptomycin was used for T-cell culture.